The Christie NHS Foundation Trust Breast Cancer Pathway Analytics

  • Research type

    Research Study

  • Full title

    The Christie Breast Cancer Pathway Analytics

  • IRAS ID

    237698

  • Contact name

    Richard Granieri

  • Contact email

    RGranieri@uk.imshealth.com

  • Sponsor organisation

    IQVIA

  • Clinicaltrials.gov Identifier

    ODR1718_186, ODR reference (pre-submission)

  • Duration of Study in the UK

    0 years, 4 months, 0 days

  • Research summary

    Breast cancer is the most common cancer in the UK, and breast cancer deaths in England are most frequent in females living in the most deprived areas of the country. Significant differences remain in the presentation and management of breast cancer that are associated with age, deprivation, and ethnicity leading to inequality of access to care.

    This project aims to understand the variations amongst breast care patient journeys (pathways) generated during routine delivery of cancer services at the Christie and referring centres within the Greater Manchester (GM) system. The intent of the study is to identify service optimization opportunities that reduce inequalities of access to breast cancer treatment. Information from the Hospital Episode Statistics (HES) and Cancer Analysis System (CAS) will be used to explore these patient pathways.

  • REC name

    North West - Greater Manchester East Research Ethics Committee

  • REC reference

    17/NW/0738

  • Date of REC Opinion

    21 Dec 2017

  • REC opinion

    Favourable Opinion